Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Resident memory CD8+ T cells within cancer islands mediate survival in breast cancer patients
Colt A. Egelston, … , Yuan Yuan, Peter P. Lee
Colt A. Egelston, … , Yuan Yuan, Peter P. Lee
Published August 29, 2019
Citation Information: JCI Insight. 2019;4(19):e130000. https://doi.org/10.1172/jci.insight.130000.
View: Text | PDF
Research Article Immunology Oncology

Resident memory CD8+ T cells within cancer islands mediate survival in breast cancer patients

  • Text
  • PDF
Abstract

CD8+ tumor-infiltrating lymphocytes (TILs) correlate with relapse-free survival (RFS) in most cancer types, including breast cancer. However, subset composition, functional status, and spatial location of CD8+ TILs in relation to RFS in human breast tumors remain unclear. Spatial tissue analysis via quantitative immunofluorescence showed that infiltration of CD8+ T cells into cancer islands was more significantly associated with RFS than CD8+ T cell infiltration into either tumor stroma or total tumor. Localization into cancer islands within tumors is mediated by expression of the integrin CD103, which is a marker for tissue-resident memory T cells (TRMs). Analysis of fresh tumor samples revealed that CD8+ TRMs are functionally similar to other CD8+ TILs, suggesting that the basis of their protective effect is their spatial distribution rather than functional differences. Indeed, CD103+ TRMs, as compared with CD103–CD8+ TILs, are enriched within cancer islands, and CD8+ TRM proximity to cancer cells drives the association of CD8+ TIL densities with RFS. Together, these findings reveal the importance of cancer island–localized CD8+ TRMs in surveillance of the breast tumor microenvironment and as a critical determinant of RFS in patients with breast cancer.

Authors

Colt A. Egelston, Christian Avalos, Travis Y. Tu, Anthony Rosario, Roger Wang, Shawn Solomon, Gayathri Srinivasan, Michael S. Nelson, Yinghui Huang, Min Hui Lim, Diana L. Simons, Ting-Fang He, John H. Yim, Laura Kruper, Joanne Mortimer, Susan Yost, Weihua Guo, Christopher Ruel, Paul H. Frankel, Yuan Yuan, Peter P. Lee

×

Figure 2

CD8+ tissue-resident memory T cells are a major population of CD8+ T cells in human breast tumors and NCBTs.

Options: View larger image (or click on image) Download as PowerPoint
CD8+ tissue-resident memory T cells are a major population of CD8+ T cel...
(A) Single-cell suspensions from peripheral blood mononuclear cells (PBMCs), tumors, and NCBTs were examined for expression of memory T cell and tissue-resident memory T cell (TRM) canonical markers CD45RA, CCR7, CD69, and CD103 by flow cytometry as shown. (B) Frequencies of CD8+ T cells in each tissue compartment that were CD45RA+CCR7+ (naive), CD45RA–CCR7+ (central memory, CM), CD45RA–CCR7– (effector memory, EM), or CD45RA+CCR7– (effector memory RA+, EMRA) are summarized. (C) Frequencies of CD45RA–CD8+ T cells in each tissue compartment expressing various patterns of CD69 and CD103 are summarized. (D) CD103+CD8+ T cells and CD103–CD8+ T cells from breast tumors and NCBTs were assessed by real-time PCR for gene expression. Gene expression and statistics shown are relative to control circulating memory CD8+ T cells. Each symbol represents data from a unique patient sample. Tumor samples n = 36. NCBT samples n = 21. PBMC samples n = 24. Significance was calculated using 1-way ANOVA and Holm-Šídák multiple-comparisons tests. *P < 0.05; **P < 0.01, ***P < 0.001, and ****P < 0.0001.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts